Perceptive Advisors
$6.4B 13F equity value
112 Holdings
Quarter ended June 30, 2026
The latest 13F on file for Perceptive Advisors covers the quarter ended June 30, 2026. Institutional managers report holdings quarterly to the SEC, so each filing is a snapshot of positions held on that date.
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| PRAX | PRAXIS PRECISION MEDICINES I | 2,035,986 | $682M | 10.6% |
| SYRE | SPYRE THERAPEUTICS INC | 4,319,496 | $383M | 6.0% |
| CELC | CELCUITY INC | 3,197,200 | $334M | 5.2% |
| ASND | ASCENDIS PHARMA A/S | 1,163,721 | $310M | 4.8% |
| RYTM | RHYTHM PHARMACEUTICALS INC | 2,586,295 | $287M | 4.5% |
| ROIV | ROIVANT SCIENCES LTD | 8,085,461 | $286M | 4.5% |
| RLAY | RELAY THERAPEUTICS INC | 14,106,187 | $264M | 4.1% |
| TVTX | TRAVERE THERAPEUTICS INC | 3,752,574 | $213M | 3.3% |
| KARD | KARDIGAN INC | 8,200,662 | $196M | 3.0% |
| NUVL | NUVALENT INC | 1,580,505 | $195M | 3.0% |
Track Perceptive Advisors's 13F portfolio: $6.4B in reported holdings, 112 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}